📊 Evidence-Based Reference

Philips Intellivue MP5 Patient Monitor

Philips Medizin Systeme Boblingen

Compare similar devices

Summary: The Philips IntelliVue MP5 is a patient monitor designed for continuous monitoring of vital signs. It is primarily used in hospital settings to track patient status. Key evidence highlights issues with alarm fatigue and the potential for early warning scoring to prevent failure to rescue.

FDA Clearance Information

Pathway ? 510(k)
Number ? K083228 ↗
Decision Date ? November 24, 2008
Product Code ? MHX
Device Class ? Class 2
Evidence ? 419 studies

The Philips IntelliVue MP5 Patient Monitor was cleared by the FDA via the 510(k) pathway on November 24, 2008. It is manufactured by Philips Medizin Systeme Boblingen and is classified as a Class 2 device under the product code MHX.

What It Is

The Philips IntelliVue MP5 is a patient monitoring device that provides continuous surveillance of vital signs such as heart rate, blood pressure, and oxygen saturation. It is intended for use in various clinical settings to assist healthcare providers in monitoring patient status and making informed clinical decisions.

FDA-Cleared Indications

  • Monitoring and displaying physiologic parameters in patients under the care of healthcare professionals.
  • Monitoring parameters such as electrocardiographic heart rate, noninvasive blood pressure, and oxygen saturation when the applicable modules and accessories are configured.
  • Providing alarms and recorded or displayed trends to help clinicians recognize changes in a patient's monitored condition.

Clinical Applications

  • Continuous vital-sign monitoring of hospitalized patients.
  • Monitoring patients in medical-surgical and other general-care environments.
  • Monitoring patients during transport or short-term observation when the appropriate monitor configuration is used.
  • Displaying physiologic data and alarms for clinician review.

Reported off-label uses

  • Use as part of hospital early-warning or rapid-response scoring systems to identify possible clinical deterioration.
  • Use in clinical studies to collect or analyze trends in monitored vital signs.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Evidence Summary

The available literature includes two studies: one published in 2011 and another with an unknown publication date. These studies explore the impact of monitoring devices on alarm fatigue and the use of early warning scoring systems to prevent failure to rescue.

Reported Outcomes

Published studies report that the high frequency of false alarms from monitoring devices can lead to alarm fatigue, potentially impacting patient care. Another study suggests that early warning scoring systems may help in preventing failure to rescue, although specific outcomes were not detailed.

Safety Profile

Reported complications include alarm fatigue due to the high frequency of false or unnecessary alarms, which can desensitize staff and lead to missed critical alarms. No other specific safety data were provided in the studies.

Evidence Limitations

The evidence is limited by the small number of studies and lack of detailed outcomes and safety data. Further research is needed to quantify the impact of alarm fatigue and to evaluate the effectiveness of early warning scoring systems in diverse clinical settings.

Practical Considerations

  • This is a monitoring system, not a treatment device; it does not diagnose or treat the underlying cause of an abnormal reading.
  • Available measurements depend on the installed modules, software, cables, sensors, and disposable accessories. Accessories must be compatible with the specific monitor configuration.
  • The monitor should be used by trained healthcare personnel, with alarm limits and sensor placement checked for each patient.
  • MRI compatibility depends on the exact monitor, components, and location. The MP5 and its accessories should not be taken into an MRI environment unless Philips labeling specifically permits that configuration.
  • Poor sensor contact, motion, low perfusion, electrical interference, or incorrect cuff size can produce inaccurate readings; abnormal values should be assessed clinically.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What are the clinical indications for Philips IntelliVue MP5?

The Philips IntelliVue MP5 is indicated for continuous monitoring of vital signs in hospital settings, particularly on medical/surgical floors.

What outcomes have been reported in clinical studies?

Studies highlight issues with alarm fatigue and suggest that early warning scoring may help prevent failure to rescue.

What complications have been reported?

Safety data indicate alarm fatigue as a complication due to frequent false alarms, potentially leading to missed critical alarms.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you